Aging and sarcopenia.
Thompson
D D
DD
Pfizer Global Research and Development, New London, CT 06320, USA. david.d.thompson@pfizer.com
D000203:Activities of Daily Living; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000473:pathology*; D040561:Assisted Living Facilities / Q000639:trends; D016330:Frail Elderly; D013006:Growth Hormone / Q000172:deficiency / Q000378:metabolism; D006299:Health Services for the Aged / Q000639:trends*; D006801:Humans; D018908:Muscle Weakness / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D009133:Muscular Atrophy / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D020511:Neuromuscular Junction Diseases / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use
C433143:CP 424391; D010880:Piperidines; D011720:Pyrazoles; D013006:Growth Hormone